A multi-institutional collaborative project on ovarian cancer will be conducted by the National Functional Genomics Center (NFGC), supported and funded by the US Army Medical Research & Material Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC).
The first phase of the project will see an investment of $500,000.
The group will use a biologically-driven approach to differentiate gene expression and oncogene activation of copy number and point mutations in preclinical models by analysing ovarian cancer cells and ovarian cancer stem cells.
The consortium will also demonstrate platinum resistance and interactions between ovarian cancer cells and the immune environment.
NFGC discovers molecular signatures of cancer that allows military and civilian personnel treatment based on individual's genetic profile.
Participants on this project will be from Moffitt Cancer Center, University of Michigan Comprehensive Cancer Center and Medical School, Barbara Ann Karmanos Cancer Institute, The University of North Carolina at Chapel Hill, Southeast Nebraska Cancer Center and Hawaii Institute for Molecular Sciences to share their scientific expertise and knowledge.
By staff writer.